Trials / Completed
CompletedNCT03861559
Onset of Action of Mometasone Furoate (MK-0887/SCH 032088) Nasal Spray Compared With Placebo in Seasonal Allergic Rhinitis (C93-184)
Onset of Action of Mometasone Furoate (SCH 32088) Nasal Spray 50 mcg/Spray vs Placebo in Seasonal Allergic Rhinitis (Study No. C93-184).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 201 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This study investigated the onset of symptom relief following initiation of treatment with mometasone furoate (MK-0887/SCH 032088) 200 mcg administered once daily compared with placebo for 14 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mometasone furoate nasal spray | intranasal administration |
| DRUG | placebo nasal spray | intranasal administration |
Timeline
- Start date
- 1994-03-30
- Primary completion
- 1994-06-27
- Completion
- 1994-07-07
- First posted
- 2019-03-04
- Last updated
- 2022-02-09
- Results posted
- 2019-09-20
Source: ClinicalTrials.gov record NCT03861559. Inclusion in this directory is not an endorsement.